OLDWICK, N.J., April 2, 2019 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced the appointment of Douglas Jacobstein, M.D., as Vice President of Clinical...
from PR Newswire: https://ift.tt/2FRB0Y4
No comments:
Post a Comment